CD63 and soft tissue sarcoma: We found significantly higher counts of activated platelet-derived (CD62P- and CD63– positive) microvesicles in soft tissue sarcoma patients with localized and metastasized disease with a positive history of VTE, compared to sarcoma patients without a history of VTE.